ProfileGDS4718 / 1568814_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 36% 30% 35% 34% 36% 33% 38% 41% 39% 35% 37% 36% 37% 42% 35% 35% 38% 39% 38% 42% 38% 37% 36% 38% 36% 38% 33% 37% 38% 39% 39% 34% 41% 41% 37% 38% 36% 38% 43% 31% 37% 36% 36% 38% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.8129636
GSM549102patient 115, normal, homogenized [OPG study]4.5485830
GSM549104patient 119, normal, homogenized [OPG study]4.7334235
GSM549108patient 138, normal, homogenized [OPG study]4.7678634
GSM549119patient 077, normal, homogenized [OPG study]4.8236836
GSM549133patient 032, cancer, homogenized [OPG study]4.6211733
GSM549139patient 042, cancer, homogenized [OPG study]4.8703138
GSM549099patient 107, normal, homogenized [OPG study]5.0369841
GSM549109patient 139, normal, homogenized [OPG study]4.9616439
GSM549110patient 046, normal, homogenized [OPG study]4.7616935
GSM549114patient 063, normal, homogenized [OPG study]4.801237
GSM549122patient 082, normal, homogenized [OPG study]4.7983636
GSM549134patient 033, cancer, homogenized [OPG study]4.8586737
GSM549136patient 036, cancer, homogenized [OPG study]5.0370342
GSM549140patient 044, cancer, homogenized [OPG study]4.6960835
GSM549111patient 047, normal, homogenized [OPG study]4.7449735
GSM549113patient 057, normal, homogenized [OPG study]4.8457938
GSM549132patient 031, cancer, homogenized [OPG study]4.9282739
GSM549137patient 038, cancer, homogenized [OPG study]4.8908938
GSM549142patient 047, cancer, homogenized [OPG study]5.2005242
GSM549100patient 110, normal, homogenized [OPG study]4.8996238
GSM549107patient 135, normal, homogenized [OPG study]4.812837
GSM549115patient 068, normal, homogenized [OPG study]4.7536336
GSM549116patient 072, normal, homogenized [OPG study]4.8920738
GSM549120patient 078, normal, homogenized [OPG study]4.8194436
GSM549131patient 030, cancer, homogenized [OPG study]4.8287938
GSM549118patient 074, normal, homogenized [OPG study]4.6687133
GSM549129patient 027, cancer, homogenized [OPG study]4.8680537
GSM549123patient 088, normal, homogenized [OPG study]4.8874338
GSM549124patient 006, cancer, homogenized [OPG study]4.9699639
GSM549126patient 015, cancer, homogenized [OPG study]4.955839
GSM549128patient 025, cancer, homogenized [OPG study]4.6928634
GSM549103patient 117, normal, homogenized [OPG study]5.1048641
GSM549117patient 073, normal, homogenized [OPG study]4.985241
GSM549138patient 041, cancer, homogenized [OPG study]4.8091737
GSM549141patient 045, cancer, homogenized [OPG study]4.8090438
GSM549130patient 028, cancer, homogenized [OPG study]4.8194436
GSM549101patient 111, normal, homogenized [OPG study]4.9461638
GSM549105patient 128, normal, homogenized [OPG study]5.1629843
GSM549106patient 134, normal, homogenized [OPG study]4.555631
GSM549112patient 048, normal, homogenized [OPG study]4.8640637
GSM549125patient 011, cancer, homogenized [OPG study]4.796236
GSM549127patient 024, cancer, homogenized [OPG study]4.8041536
GSM549135patient 035, cancer, homogenized [OPG study]4.8380438